National Drug and Alcohol Research Centre. (2025) NDARC fact sheet: methadone. Sydney: National Drug and Alcohol Research Centre.
Preview | Title | Contact |
---|---|---|
|
PDF (Methadone)
1MB |
Methadone is a prescription opioid medicine with a range of uses, including treating chronic non-cancer and cancer pain and, more commonly, opioid dependence. It is a common opioid agonist treatment (OAT). Those participating in a methadone treatment program are generally provided with a daily dose of the medicine in an oral solution or syrup, which is swallowed. Methadone is prescribed by a doctor as part of a treatment plan, with the dose and treatment duration based on the needs of the individual.
By providing a regular and stable opioid dose, methadone removes the need for additional opioids and helps to stabilise opioid-dependent individuals. Methadone can also promote changes in the routines and habits that may be associated with the use of heroin or other opioids. This can help a person achieve their treatment goals, which may be to become abstinent, or reduce their opioid use. Opioid dependence treatment using methadone can be long-term, lasting months or years as a form of maintenance therapy, or short-term for approximately five to 14 days to treat withdrawal...
B Substances > Opioids (opiates) > Opioid product > Methadone
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
VA Geographic area > Australia and Oceania > Australia
Repository Staff Only: item control page